Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab and Ultrasound in Rheumatoid Arthritis
NCT02056184Phase 4Completed
- Sponsor
- University of Leeds
- Start
- Dec 2013
- Primary completion
- Dec 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of adalimumab in rheumatoid arthritis (RA), sponsored by University of Leeds. Primary endpoint: Proportion of patients with a decrease in Power Doppler at 48 weeks. Started Dec 2013; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02056184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02056184.